<scp>FMOD</scp> expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot studyMarc Sorigué, Lurdes Zamora, Jordi Juncà et al.|Cytometry Part B Clinical Cytometry|2020Cited by 15
Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinomaLucas D. Caeiro, Lluís Morey, Ho Lam Chan et al.|Genes & Development|2024Cited by 8
Role of ABL Gene Mutations in Chronic Myeloid Leukemia Patients Resistant to Imatinib and Results of Treatment Shift to Second-Generation Tyrosine Kinase InhibitorsSílvia Marcé, Fuensanta Millá, Lurdes Zamora et al.|Blood|2011Cited by 0
Clinical and Biological Characteristics According to the Burden of JAK2V617F Mutated Allele in BCR-ABL Negative MPNsLurdes Zamora, Fuensanta Millá, Marta Cabezón et al.|Blood|2012Cited by 0